Dashboard › Demo Universe › Summit Chemical
Summit Chemical · SMCH
DEMO DATAUNDERWRITING ASSUMPTIONPASSFinancial statements DEMO DATA ANALYST PROJECTION
| $M | FY2022A | FY2023A | FY2024A | FY2025A | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.7B | $2.6B | $2.6B | $2.0B | $1.7B | $1.7B | $1.7B | $1.7B |
| % growth | 10.2% | -1.9% | -1.9% | -23.4% | -13.0% | -2.6% | 1.0% | 2.0% | |
| Direct costs / COGS | $1.8B | $2.0B | $1.9B | $1.9B | $1.6B | $1.4B | $1.4B | $1.4B | $1.4B |
| Gross profit (NOI for real estate) | $686.0M | $742.5M | $702.3M | $676.0M | $374.4M | $284.2M | $297.0M | $320.4M | $347.7M |
| % margin | 28.0% | 27.5% | 26.5% | 26.0% | 18.8% | 16.4% | 17.6% | 18.8% | 20.0% |
| Operating expenses (cash, adjusted) | $269.5M | $297.0M | $291.5M | $286.0M | $219.1M | $190.6M | $185.6M | $187.5M | $191.2M |
| EBITDA (company-adjusted basis) | $416.5M | $445.5M | $410.8M | $390.0M | $155.3M | $93.6M | $111.4M | $133.0M | $156.5M |
| % margin | 17.0% | 16.5% | 15.5% | 15.0% | 7.8% | 5.4% | 6.6% | 7.8% | 9.0% |
| D&A | $122.5M | $135.0M | $132.5M | $130.0M | $99.6M | $86.6M | $84.4M | $85.2M | $86.9M |
| Share-based compensation | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| EBIT | $294.0M | $310.5M | $278.3M | $260.0M | $55.8M | $6.9M | $27.0M | $47.7M | $69.5M |
| Interest expense | $104.5M | $110.6M | $116.8M | $122.9M | $152.9M | $139.8M | $136.6M | $135.7M | $134.7M |
| EBT | $189.5M | $199.9M | $161.5M | $137.1M | ($97.2M) | ($132.9M) | ($109.6M) | ($87.9M) | ($65.2M) |
| Taxes | $47.4M | $50.0M | $40.4M | $34.3M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income (model basis) | $142.1M | $149.9M | $121.1M | $102.8M | ($97.2M) | ($132.9M) | ($109.6M) | ($87.9M) | ($65.2M) |
| Capex | $134.8M | $148.5M | $145.8M | $143.0M | $87.6M | $76.2M | $74.3M | $75.0M | $76.5M |
| Working capital & other cash items | $10.7M | $37.5M | ($7.5M) | ($7.5M) | ($79.3M) | ($28.4M) | $3.4M | $12.8M | $15.5M |
| Free cash flow | $119.2M | $98.9M | $115.4M | $97.3M | ($5.9M) | ($94.0M) | ($102.9M) | ($90.5M) | ($70.3M) |
Historical columns are fictional demo inputs. Projections flow from the selected scenario’s assumptions (Scenarios tab): interest accrues on beginning balances by tranche; floating tranches use MAX(SOFR, floor) + spread + scenario shock; PIK accrues to principal. FCF = net income + D&A + SBC + PIK − capex − ΔNWC / other. Impairments, restructuring and other one-offs are excluded from EBITDA and net income and sit in the cash plug.
Sources & data lineage (3)
| Source | Document | Data type | Period | Accession | Doc date | Retrieved | Class |
|---|---|---|---|---|---|---|---|
| CreditIQ demo dataset | Summit Chemical — illustrative financial statements FY2022–FY2025 | Income statement / cash flow | FY2022–FY2025 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Summit Chemical — illustrative capital structure & covenants | Debt schedule | As of 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Illustrative indicative bid marks (% of par) | Market price | 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |